This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Rianne Ellenbroek
Principle at BGV (BioGeneration Ventures)


Rianne Ellenbroek is Principal at BGV and joined the company in 2020 as Investment Manager of BGV's pre-seed fund FIRST where she led investments in TargED Biopharmaceuticals, River Biomedics, Phlox Therapeutics and Phosphoenix. Prior to joining BGV, she was an Associate at INKEF Capital. Rianne is a medical biologist by training. She obtained her PhD at Leiden University that was focused on regenerative medicine for metabolic diseases, while performing part of her activities at biotech company Galapagos. Winning a grant facilitated her to take a position as postdoctoral fellow at the Kovler Diabetes Center at the University of Chicago. Next to performing her research, she was a fellow at the university’s Technology Transfer Office which has sparked her interest in the early stages of life sciences ventures.

Agenda Sessions

  • Fireside chat in collaboration with YVC